Comparison of four renal function estimation equations for pharmacokinetic modeling of gentamicin in geriatric patients

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 1862-1869

  Charhon, Nicolas ^a   Neely, Michael N ^a   Bourguignon, Laurent ^a,c   Maire, Pascal ^a,c   Jelliffe, Roger W ^b   Goutellea, Sylvain ^a,c  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN;

ACCURACY; AGED; ALGORITHM; ARTICLE; BODY SURFACE; COCKCROFT GAULT EQUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HUMAN; INFECTION; JELLIFFE EQUATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL PARAMETERS; MODIFICATION OF DIET IN RENAL DISEASE EQUATION; MODIFIED MODIFICATION OF DIET IN RENAL DISEASE EQUATION; POPULATION MODEL; PREDICTIVE VALUE; PRIORITY JOURNAL; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BIAS (EPIDEMIOLOGY); CREATININE; DATA INTERPRETATION, STATISTICAL; FEMALE; GENTAMICINS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MODELS, STATISTICAL; POPULATION; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 84858661714     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05634-11     Document Type: Article

References (41)

1. Akaike H. 1974. A new look at the statistical model identification. IEEE Trans. Automatic Control. 19:716-723.
2. Avent ML, Rogers BA, Cheng AC, Paterson DL. 2011. Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity. Intern. Med. J. 41:441-449.
3. Bauer LA, Edwards WA, Dellinger EP, Simonowitz DA. 1983. Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. Eur. J. Clin. Pharmacol. 24:643-647. (Pubitemid 13092243)
4. Begg EJ, Barclay ML. 1995. Aminoglycosides-50 years on. Br. J. Clin. Pharmacol. 39:597- 603.
5. Bookstaver PB, Johnson JW, McCoy TP, Stewart D, Williamson JC. 2008. Modification of diet in renal disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination. Ann. Pharmacother. 42:1758 -1765.
6. Bourguignon L, et al. 2009. Amikacin pharmacokinetics in adults: a variability that question the dose calculation based on weight. Therapie 64:47-53.
7. Chumlea WC, et al. 1998. Stature prediction equations for elderly non-Hispanic white, non-Hispanic black, and Mexican-American persons developed from NHANES III data. J. Am. Diet Assoc. 98:137-142.
8. Cockcroft DW, Gault MH. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41.
9. Dager WE. 1994. Aminoglycoside pharmacokinetics: volume of distribution in specific adult patient subgroups. Ann. Pharmacother. 28:944-951. (Pubitemid 24262666)
10. Debord J, Charmes JP, Marquet P, Merle L, Lachatre G. 1997. Population pharmacokinetics of amikacin in geriatric patients studied with the NPEM-2 algorithm. Int. J. Clin. Pharmacol. Ther. 35:24-27. (Pubitemid 27056791)
11. Dowling TC, Matzke GR, Murphy JE, Burckart GJ. 2010. Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches. Pharmacotherapy 30:776-786.
12. Du Bois D, Du Bois EF. 1916. A formula to estimate the approximate surface area if height and weight be known. Nutrition 5:303-313.
13. Gehan EA, George SL. 1970. Estimation of human body surface area from height and weight. Cancer Chemother. Rep. 54:225-235.
14. Gill J, Malyuk R, Djurdjev O, Levin A. 2007. Use of GFR equations to adjust drug doses in an elderly multi-ethnic group-a cautionary tale. Nephrol. Dial. Transplant. 22:2894 -2899.
15. Goutelle, S, Bourguignon. L, Ducher M, Maire P. 2009. Comment: modification of diet in renal disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination. Ann. Pharmacother. 43: 1145-1146.
16. Hanser AM, et al. 2001. Comparison of methods for the determination of blood creatinine. Ann. Biol. Clin. (Paris) 59:737-742.
17. Hickling KG, Begg EJ, Perry RE, Atkinson HC, Sharman JR. 1991. Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients. Crit. Care Med. 19:1041-1047.
18. Jelliffe R. 2002. Estimation of creatinine clearance in patients with unstable renal function, without a urine specimen. Am. J. Nephrol. 22:320 -324.
19. Jelliffe R, Bayard D, Milman M, Van Guilder M, Schumitzky A. 2000. Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimens. Ther. Drug Monit. 22:346 -353.
20. Jelliffe RW, Iglesias T, Hurst AK, Foo KA, Rodriguez J. 1991. Individualising gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring strategies. Clin. Pharmacokinet. 21:461-478.
21. Jelliffe RW, et al. 1998. Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new "multiple model" dosage design, Bayesian feedback and individualised target goals. Clin. Pharmacokinet. 34:57-77. (Pubitemid 28041092)
22. Keller F, Erdmann K, Giehl M, Buettner P. 1993. Nonparametric meta-analysis of published data on kidney-function dependence of pharmacokinetic parameters for the aminoglycoside netilmicin. Clin. Pharmacokinet. 25:71-79. (Pubitemid 23184524)
23. Kirkpatrick CM, Duffull SB, Begg EJ. 1999. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily. Br. J. Clin. Pharmacol. 47:637-643. (Pubitemid 29257661)
24. Leary R, Jelliffe R, Schumitzky A, Van Guilder M. 2001. An adaptive grid nonparametric approach to pharmacokinetic and dynamic (PK/PD) population models, p. 389-394. Proceedings of the 14th IEEE Symposium on Computer-Based Medical Systems. CBMS, Bethesda, MD.
25. Levey AS, Greene T, Kusek JW, Beck GJ. 2000. A simplified equation to predict glomerular filtration rate from serum creatinine. J. Am. Soc. Nephrol. 11:155A.
26. Luft FC, et al. 1978. Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis. Antimicrob. Agents Chemother. 14:403-407. (Pubitemid 9027810)
27. Mallet A, et al. 1988. Handling covariates in population pharmacokinetics, with an application to gentamicin. Biomed. Meas. Infect. Control 2:138-146.
28. Nagai J, Tanaka H, Nakanishi N, Murakami T, Takano M. 2001. Role of megalin in renal handling of aminoglycosides. Am. J. Physiol. Renal Physiol. 281:F337-F344.
29. Pai MP, Nafziger AN, Bertino JS, Jr. 2011. Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients. Antimicrob. Agents Chemother. 55:4006-4011.
30. Pastoriza-Munoz E, Bowman RL, Kaloyanides GJ. 1979. Renal tubular transport of gentamicin in the rat. Kidney Int. 16:440-450. (Pubitemid 10195855)
31. Roberts GW, Ibsen PM, Schioler CT. 2009. Modified diet in renal disease method overestimates renal function in selected elderly patients. Age Ageing 38:698 -703.
32. Ryzner KL. 2010. Evaluation of aminoglycoside clearance using the modification of diet in renal disease equation versus the Cockcroft-Gault equation as a marker of glomerular filtration rate. Ann. Pharmacother. 44: 1030-1037.
33. Schentag JJ, et al. 1977. Gentamicin disposition and tissue accumulation on multiple dosing. J. Pharmacokinet. Biopharm. 5:559-577. (Pubitemid 8253666)
34. Schentag JJ, Lasezkay G, Cumbo TJ, Plaut ME, Jusko WJ. 1978. Accumulation pharmacokinetics of tobramycin. Antimicrob. Agents Chemother. 13:649-656. (Pubitemid 8321215)
35. Sheiner LB, Beal SL. 1981. Some suggestions for measuring predictive performance. J. Pharmacokinet. Biopharm. 9:503-512.
36. Tod M. 2001. Individualising aminoglycoside dosage regimens after therapeutic drug monitoring. Simple or complex pharmacokinetic methods? Clin. Pharmacokinet. 40:803-814. (Pubitemid 33095997)
37. Van Pottelbergh G, Van Heden L, Mathei C, Degryse J. 2010. Methods to evaluate renal function in elderly patients: a systematic literature review. Age Ageing 39:542-548.
38. Wakefield J, Bennett J. 1996. The Bayesian modeling of covariates for population pharmacokinetic models. J. Am. Stat. Assoc. 91:917-927.
39. Wenk M, Spring P, Vozeh S, Follath F. 1979. Multicompartment pharmacokinetics of netilmicin. Eur. J. Clin. Pharmacol. 16:331-334. (Pubitemid 10212153)
40. Xuan D, Nicolau DP, Nightingale CH. 2004. Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing. Int. J. Antimicrob. Agents 23:291-295. (Pubitemid 38283599)
41. Zaske DE, et al. 1982. Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations. Antimicrob. Agents Chemother. 21:407-411. (Pubitemid 12117784)